What's new in hemochromatosis

Current Opinion in Hematology

Volumn 8, Issue 2, 2001, Pages 98-104

  Gochee, Peter A ^a   Powell, Lawrie W ^a,b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HFE PROTEIN; IRON; UNCLASSIFIED DRUG;

ARTICLE; CARDIOMYOPATHY; DIABETES MELLITUS; DISEASE COURSE; DISORDERS OF METAL METABOLISM; EARLY DIAGNOSIS; GENE MUTATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC SCREENING; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; IRON TRANSPORT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PARENCHYMA; PATHOGENESIS; PATHOPHYSIOLOGY; PHLEBOTOMY; PRIORITY JOURNAL;

HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IRON; MEMBRANE PROTEINS; MUTATION;

EID: 0035097309     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200103000-00007     Document Type: Article

References (73)

1. Glycosurie, diabète, sucré
2. Über hämochromatose
3. Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by HLA typing
4. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
5. Molecular medicine and hemochromatosis: At the crossroads
6. Hemochromatosis and other iron storage disorders
7. Hepatic Pathology in relatives of patients with haemochromatosis
8. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis
9. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis
10. Elevated serum type IV collagen: A sensitive indicator of the presence of cirrhosis in haemochromatosis
11. Crystal structure of the hemochromatosis protein HFE and the characterization of its interaction with transferrin receptor
12. The hemochromatosis founder mutation disrupts b2 microglobulin interaction and cell surface expression
13. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding
14. Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with Beta2-microglobulin, intracellular processing and cell surface expression of the HFE protein in COD-7 cells
15. HLA-H gene mutations and haemochromatosis: The likely association of H63D with mild phenotype and the detection of S65C, a novel variant in exon 2
16. HFE mutations analysis in 711 hemochromatosis probands: Evidence for S65C implications in mild form of hemochromatosis
17. Two novel missense mutations of the HFE gene (1105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands
18. HFE S65C variant is not associated with increased tranferrin saturation in voluntary blood donors
19. A single nucleotide deletion in the putative hemochromatosis gene in a patient who is negative for the C282Y and H63D mutations
20. A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote
21. Global prevalence of putative haemochromatosis mutations
22. The significance of haemochromatosis gene mutations in the general population: Implications for screening
23. Prevalence of the C282Y mutation in Brittany: Penetrance of genetic hemochromatosis?
24. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany
25. A retrospective anonymous pilot study in the screening of newborns for HFE mutations in Scandinavian populations
26. A population-based study of the clinical expression of the hemochromatosis gene
27. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients
28. Juvenile and adult hemochromatosis are distinct genetic disorders
29. Juvenile hemochromatosis locus maps to chromosome 1q
30. Juvenile idiopathic haemochromatosis: A life-threatening disorder presenting as hypogonadotropic hypogonadism
31. Recurrence of neonatal haemochromatosis in half sibs born of unaffected mothers
32. Neonatal hemochromatosis: Report of successful orthotopic liver transplatation
33. Neonatal hemochromatosis
34. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene
35. Dietary iron overload persists in sub-Saharan Africa
36. Is there a link between African iron overload and the described mutations of the hereditary haemochromatosis gene?
37. African iron overload
38. Iron overload in Africa - Interaction between a gene and dietary iron content
39. Causes of iron overload
40. Siderosis in the Bantu: The relationship between iron overload and cirrhosis
41. Siderosis in the Bantu: A comparison of the incidence in males and females
42. Familial iron overload with possible autosomal dominant inheritance
43. The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor
44. Coordinate post-transcriptional regulation of ferritin and transferrin receptor expression: The role of regulated RNA-protein interaction
45. Cloning and characterization of a mammalian proton-coupled metal-ion transporter
46. Microcytic anaemia mice have a mutation in Nramp2, a cadidate iron transporter gene
47. Nramp2 is mutated in the anemic Belgrade (b) rat: Evidence of a role from Nramp2 in endosomal iron transport
48. Hephastin, a ceruloplasmin homologue implicated in intestinal iron transportation, is defective in the sla mouse
49. Lipid peroxidation and asociated hepatic organelle dysfunction in iron overload
50. Iron and the liver: Genetic hemochromatosis and other hepatic iron overload disorders
51. Genetic emochromatosis and Wilson's Disease: Role for oxidant stress?
52. Hepatic stellate cell activation in genetic hemochromatosis: Lobular distribution, effect of increasing iron and response to phlebotomy
53. Alcohol and iron: A radical combination?
54. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda
55. High prevalence of His63Asp HFE mutation in Italian patients with porphyria cutanea tarda
56. The C282Y mutation in hemochromatosis (HFE) gene and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients
57. Spectrum of mutations in the HFE gene implications in haemochromatosis and porphyria
58. Heterozygosity for hereditary hemochromatosis gene is associated with cardiovascular death in women
59. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene cys282tyr mutation: A prospective cohort study in men in Eastern Finland
60. Iron and the genetics of cardiovascular disease
61. Relation of HFE gene mutations, high iron stores and early onset coronary artery disease
62. Prelvalence of hereditary haemochromatosis in premature atherosclerotic vascular disease
63. Survival and causes of death in cirrhotic and non-cirrhotic patients with primary hemochromatosis
64. Increased liver iron stores in patients with hepatocellular carcinoma developed on a non cirrhotic liver
65. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: A study of 185 patients
66. Genetic irony beyond haemochromatosis: Clinical effect of HLA-H mutations
67. Hereditary haemochromatosis: Gene discovery and its implication for population-based screening
68. Automated measurement of unsaturated iron binding capacity allows a cost effective, ongoing strategy for screening of haemochromstosis
69. Automated measurement of unsaturated iron binding capacity is an effective strategy for C282Y homozygous haemochromatosis
70. Population screening for hemochromatosis: A comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors
71. Long-term survival in patients with hereditary hemochromatosis
72. Effectiveness of regular surveillance for hepatocellular carcinoma in haemochromatosis with cirrhosis